Canada Pension Plan Investment Board Portfolio holdings
AUM $117B
1-Year Return
24.44%
This Quarter Return
+11.65%
1 Year Return
+24.44%
3 Year Return
+87.75%
5 Year Return
+166.12%
10 Year Return
+404.19%
AUM
$95.2B
AUM Growth
+$16B
(+20%)
Cap. Flow
+$8.84B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,286
New
201
Increased
511
Reduced
299
Closed
117
Top Buys
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
Microsoft
MSFT
|
+$1.15B |
| 3 |
GE Aerospace
GE
|
+$861M |
| 4 |
Meta Platforms (Facebook)
META
|
+$383M |
| 5 |
Analog Devices
ADI
|
+$347M |
Top Sells
| 1 |
Royal Caribbean
RCL
|
+$477M |
| 2 |
Booking.com
BKNG
|
+$277M |
| 3 |
Alibaba
BABA
|
+$257M |
| 4 |
MGM Resorts International
MGM
|
+$230M |
| 5 |
Manhattan Associates
MANH
|
+$185M |
Sector Composition
| 1 | Technology | 21.73% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 11.52% |
| 4 | Communication Services | 11.24% |
| 5 | Real Estate | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
AGCO
AGCO
$8.22B
| $1.02M | ﹤0.01% |
8,300
-21,700
| -72% | -$2.67M |
|
1027
Light & Wonder
LNW
$7.41B
| $1.02M | ﹤0.01% |
+10,000
| New | +$1.02M |
|
1028
Teva Pharmaceuticals
TEVA
$21.1B
| $1.02M | ﹤0.01% |
72,000
| – | – |
|
1029
Dutch Bros
BROS
$7.37B
| $1M | ﹤0.01% |
+30,400
| New | +$1M |
|
1030
IPG Photonics
IPGP
$3.43B
| $998K | ﹤0.01% |
11,000
| – | – |
|
1031
Wyndham Hotels & Resorts
WH
$6.37B
| $990K | ﹤0.01% |
+12,900
| New | +$990K |
|
1032
Liquidia Corp
LQDA
$2.22B
| $982K | ﹤0.01% |
+66,600
| New | +$982K |
|
1033
B2Gold
BTG
$5.77B
| $980K | ﹤0.01% |
373,500
-637,300
| -63% | -$1.67M |
|
1034
Fate Therapeutics
FATE
$111M
| $974K | ﹤0.01% |
+132,700
| New | +$974K |
|
1035
Penske Automotive Group
PAG
$11.9B
| $972K | ﹤0.01% |
+6,000
| New | +$972K |
|
1036
StoneX
SNEX
$4.95B
| $963K | ﹤0.01% |
+20,567
| New | +$963K |
|
1037
Revvity
RVTY
$9.99B
| $959K | ﹤0.01% |
9,131
-12,579
| -58% | -$1.32M |
|
1038
John B. Sanfilippo & Son
JBSS
$756M
| $953K | ﹤0.01% |
9,000
-3,000
| -25% | -$318K |
|
1039
European Wax Center
EWCZ
$177M
| $946K | ﹤0.01% |
+72,900
| New | +$946K |
|
1040
MarketAxess Holdings
MKTX
$6.88B
| $943K | ﹤0.01% |
4,300
-33,500
| -89% | -$7.34M |
|
1041
RH
RH
$4.4B
| $940K | ﹤0.01% |
2,700
-71,700
| -96% | -$25M |
|
1042
Antero Resources
AR
$10B
| $931K | ﹤0.01% |
32,100
| – | – |
|
1043
RB Global
RBA
$21.9B
| $929K | ﹤0.01% |
+12,200
| New | +$929K |
|
1044
Progyny
PGNY
$1.88B
| $919K | ﹤0.01% |
+24,100
| New | +$919K |
|
1045
Mersana Therapeutics
MRSN
$35.5M
| $918K | ﹤0.01% |
+8,196
| New | +$918K |
|
1046
Sleep Number
SNBR
$209M
| $915K | ﹤0.01% |
57,100
-43,700
| -43% | -$701K |
|
1047
Doximity
DOCS
$13.5B
| $915K | ﹤0.01% |
34,000
+2,300
| +7% | +$61.9K |
|
1048
Cognex
CGNX
$7.36B
| $908K | ﹤0.01% |
21,400
+1,500
| +8% | +$63.6K |
|
|
PARA
1049
DELISTED
Paramount Global Class B
PARA
| $897K | ﹤0.01% |
+76,200
| New | +$897K |
|
1050
Couchbase
BASE
$1.35B
| $895K | ﹤0.01% |
34,000
-28,000
| -45% | -$737K |
|